Infections treated with specialty hospital care in early- and mid-life are associated with an increased subsequent risk of Alzheimer’s and Parkinson’s diseases, but not amyotrophic lateral sclerosis (ALS), according to a study by researchers from Karolinska Institutet, published in PLOS Medicine.
A Parkinson’s disease gene turns out to provide the key to modify diseases related to immunoageing
In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe Parkinson’s disease. The finding could help explain an earlier outcome of the same study, in which the drug nilotinib was able to halt motor and nonmotor (cognition and quality of life) decline in the long term.
Surgery that produced unprecedented improvements in children with rare genetic disorder may also treat Parkinson’s, Alzheimer’s Disease
Scientists find evidence that clusters of proteins associated with Parkinson’s and other diseases can induce a toxic process involving glutamate, a neurotransmitter.